首页 | 官方网站   微博 | 高级检索  
     

细胞学性质不确定甲状腺结节分子检测进展[综述]
引用本文:汪旭,李超,何天琪,郑王虎,刘伟,周雨秋,税春燕,宁玉东,蔡永聪,姜健,朱桂全,孙荣昊.细胞学性质不确定甲状腺结节分子检测进展[综述][J].国际耳鼻咽喉头颈外科杂志,2020,44(1):20-24.
作者姓名:汪旭  李超  何天琪  郑王虎  刘伟  周雨秋  税春燕  宁玉东  蔡永聪  姜健  朱桂全  孙荣昊
作者单位:成都医学院临床医学系;四川省肿瘤医院·研究所;西南医科大学附属医院耳鼻咽喉头颈外科
摘    要:随着甲状腺结节的发病及检出率日益增高,甲状腺结节的分子标记物在鉴别结节的性质,术前诊断及患者预后都有重要作用。本文总结归纳关于相关分子标记物及检测手段在甲状腺结节诊治中的更新进展,结论表明甲状腺结节的单个致病分子的研究较为成熟,多分子联合检测手段可提高诊断精确率,同时提供更加可靠的分子依据,指导手术及术后药物治疗。尽管其还未能替代“金标准-病理诊断”,但对甲状腺结节的诊断管理和治疗,必将扮演越来越重要的角色,具有广泛的应用前景。

关 键 词:甲状腺结节  分子检测  

Research progress in molecular detection of thyroid nodules with cytologically indeterminate thyroid nodules
Wang Xu,Li Chao,He Tianqi,Zheng Wanghu,Liu Wei,Zhou Yuqiu,Shui Chunyan,Ning Yudong,Cai Yongcong,Jiang Jian,Zhu Guiquan,Sun Ronghao.Research progress in molecular detection of thyroid nodules with cytologically indeterminate thyroid nodules[J].International Journal of Otolaryngology-Head and Neck Surgery,2020,44(1):20-24.
Authors:Wang Xu  Li Chao  He Tianqi  Zheng Wanghu  Liu Wei  Zhou Yuqiu  Shui Chunyan  Ning Yudong  Cai Yongcong  Jiang Jian  Zhu Guiquan  Sun Ronghao
Affiliation:(Department of Clinical Medicine,Chengdu Medical College,Chengdu 610041,China;Department of Head and Neck Surgery,Sichuan Cancer Hospital,Sichuan Institute of Cancer Research,Sichuan Cancer Prevention and Control Center,Cancer Hospital Affiliate to School of Medicine,Electronic Science and Technology,Chengdu 610041,China;Department of Otolaryngology Head and Neck Surgery,First Affiliated Hospital Southwest Medical University,Luzhou 646000,China)
Abstract:With the increasing incidence and detection rate of thyroid nodules,molecular markers of thyroid nodules play an important role in the treatment of benign and malignant nodules,as well as preoperative diagnosis and patient prognosis.This article summarizes the progress of related molecular markers and detection methods in the diagnosis and treatment of thyroid nodules.Conclusions indicate that the study of single pathogenic molecules of thyroid nodules is relatively mature.Multi-molecular combined detection methods can greatly improve the accuracy of diagnosis,and meanwhile,it provides more reliable molecular evidence to guide surgery and postoperative drug treatment.Although it has not replaced the"gold standard-pathological diagnosis",it will play an increasingly important role in the diagnosis and management of thyroid nodules,and has broad prospects.
Keywords:Thyroid Nodule  molecular detection
本文献已被 维普 等数据库收录!
点击此处可从《国际耳鼻咽喉头颈外科杂志》浏览原始摘要信息
点击此处可从《国际耳鼻咽喉头颈外科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号